Matt, Author at European Medical Journal - Page 131 of 212

Continue
5 Mins
15 Oct 2018

Preview of the 26th United European Gastroenterology (UEG) Week

Participants of the 26th edition of the annual UEG Week will arrive in the beautiful city of Vienna, Austria, for 5 days from 20th–24th October 2018…
9 Mins
13 Oct 2018

Effect of Mesenchymal Stem Cells in Autoimmune Arthritis

The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…
5 Mins
12 Oct 2018

Preview of the European Society for Medical Oncology (ESMO) 2018 Congress

From 19th–23rd October, Munich, Germany will host this year’s edition of the annual ESMO Congress at the world-famous Messe Munich convention centre.
11 Oct 2018

European Medical Journal Presents: EMJ Cardiology 6.1

The publication of EMJ Cardiology 6.1 is now available and features a full review of the European Society of Cardiology (ESC) 2018 Congress…
1 Mins
11 Oct 2018

Fibre-Optic Contact Force Catheter Efficiency and Effectiveness in Paroxysmal Atrial Fibrillation Ablation from a Large, Multinational, Prospective Registry (ABLATOR)

Over recent years, in response to the widespread use of contact force (CF) ablation catheters for the treatment of atrial fibrillation, numerous studies…
17 Mins
11 Oct 2018

Review of the European Society of Cardiology Congress 2018

Known as the largest cardiovascular conference in the world, it was apt that the high standards of the European Society of Cardiology (ESC) were matched…
10 Mins
11 Oct 2018

Guidelines, Clinical Evidence, and Real-Life Practice: How to Find Your Way in Managing Hypercholesterolaemia

Prof Masana presented evidence that low-density lipoprotein (LDL) cholesterol is a causal factor for atherosclerosis and that cardiovascular disease (CVD…
2 Mins
11 Oct 2018

Impact of a Cardiac Rehabilitation Programme After a Myocardial Infarction in Individuals Not Undergoing Revascularisation: New Horizons for a Time-Tested Intervention

Cardiac rehabilitation (CR) plays a pivotal role in the contemporary management of myocardial infarction (MI) patients and several studies have…
4 Mins
11 Oct 2018

Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEXA-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor

Andexanet alfa is a modified factor Xa (FXa) drug designed to bind and sequester FXa inhibitors and thus reverse anticoagulation…
2 Mins
11 Oct 2018

Congress Interview from the ESC Congress 2018

During the ESC 2018 Congress, we met with EMJ Cardiology’s Editor-in-Chief, Dr Çetin Erol, to ask about his experience of this year’s event and his…
We’ve noticed you’re accessing
from North/South America.